Recombinant human growth hormone was covalently linked to biotin via a six-carbon spacer arm. Biotinylation was confmed by electrophoresis and mass specvometry showed that approximately 50% of the hormone was monobiotinylated. The modified growth hormone (GH) was shown to bind to the GH receptor of IM9 human lymphoid cells with an affinity of 0.55 x lo9 M-l. Bioactivity of biotinylated GH measured in the Nb2 bioassay was 53.9% that of unlabeled Supported by a grant from the King's Joint Research Committee 0). GH. GH binding sites on human IM9 cells were visualized histochemically with the biotinylated hormone, a technique that provides a means of identifying receptors for GH on target cells in vitro. (J fiktochem Cytochem 42103-107, 1994)
Introduction
According to the original somatomedin concept, the effects of growth hormone were thought to be mediated by circulating somatomedins derived primarily from the liver (Daughaday et al., 1972) . More recent work, however, has shown that growth hormone (GH) acts directly on a variety of tissues including cartilage (Maor et al., 1989) , muscle (Isgaard et al., 1989) , and adipocytes (Grichting et al., 1983) . The "dual effector" hypothesis (Green et al., 1985) postulates that the effects of GH are confined to relatively rare stem cells in some tissues. In cartilage, for example, there appears to be considerable heterogeneity in the expression of GH receptors and responsiveness to GH may be confined to chondrocyte stem cells (Isaksson et al., 1987) . It is therefore important that techniques are available to identify individual cells expressing GH receptors. Unfortunately, standard techniques of radioreceptor assay or affinity cross-linking may not be sufficiently sensitive to identlfy target tissues in which only a minority of cells are responsive. Histochemical techniques provide one means of overcoming this problem.
Antibodies have been used extensively for localization of receptors, but it is usually necessary to purify the receptor before raising antibodies and crossreactivity with related receptors may create difficulties. Moreover, a receptor identified with an antibody is not necessarily capable of binding hormone. A panel of GH receptor ' antibodies has been shown to recognize different subpopulations of GH receptor, which could be explained by differences in structure (Barnard et al., 1985) , implying that use of antibodies may not reveal all potential binding sites.
The use of labeled ligands is an alternative method that has recently proven useful since it has become possible to produce ligands in large quantities and of high purity by recombinant technology. GH has been labeled with various radioisotopes and used to identlfy binding sites by autoradiography, an indirect method that requires long exposure times to maximize sensitivity. Nonradioactive labels such as fluorescein have been used to follow binding, aggregation, and internalization of GH in IM9 human lymphoma cells (Eshet et al., 1984) , but fading of the fluorophore on exposure to light and autofluorescence creates difficulties.
An alternative non-radioactive method is the use of the avidinbiotin system, which has been applied to many biochemical techniques including affinity chromatography and histochemistry (Bayer et al., 1979) . The effectively irreversible high-affinity binding between avidin and biotin is ideally suited for histochemistry. By attaching biotin to the ligand of interest and using avidin or streptavidin linked to peroxidase as part of the detection system, a permanent record and high resolution can be obtained. Biotinylated human GH (hGH) has been used previously by Haeuptle et al. (1983) in a heterologous system to purlfy receptors from rabbit liver and mammary gland by affinity chromatography, although not for histochemistry.
We describe here the synthesis and characterization of biotinylated hGH and its use as a histochemical probe for hGHbinding sites.
Materials and Methods
Biotinylation of Human Growth Hormone. Sulfosuccinimidyl 6 4 biotinamido) hexanoare (NHS-LC-biotin) (Pierce Eurochemie; Chester. UK) was covalently linked to recombinant hGH (Kabi Pharmacia; Milton Keynes, UK). This biotin derivative is soluble in aqueous solvents and has a sixcarbon spacer arm berween the biotin and the reactive hydroxysuccinimide ester. Human GH was incubated with NHS-LC-biotin at a 1:5 molar ratio in a SO-mM bicarbonate buffer. pH 9. for 2 hr on ice.
After the biotinylation reaction, free biotin was removed by desalting to PBS on adesaltingcolumn in a fast protein liquid chromatography (FPLC) system (Pharmacia; Milton Keynes, UK). The protein concentration was determined according to the method of Lowry et al. (1951) . Biotinylated hGH was electrophoresed under reducing conditions on 10% polyacrylamide gels (Laemmli. 1970 ). transferred to nitrocellulose sheets according to the method of Towbin et al. (1979) , and labeled with fluorescein-avidin for detection under uv light.
Biochemical Characterization of Biotinylated hGH. Electrospray mass spectra were measured on a VG BIO Q triple quadrupole atmospheric pressure mass Spectrometer equipped with a VG electrospray interface. Samples (10 pl) were injected into the electrospray source via a loop injector (Rheodyne 5717) as a solution, 20 pmollpl, in water:acetonitrile (1:l) and 1% formic acid, at a flow rate of 2 pllmin (Applied Biosystems model 140A dual syringe pump). The mass spectrometer was scanned over the mass range 750-1550 Da and the instrument was calibrated with myoglobin.
Tissue Culture. IM9 and Nb2 cells were cultured in RPMI 1640 medium with 10% (vlv) fetal calf serum (Gibco; Paisley, UK). All cells were maintained in an incubator under an atmosphere of 5% C02.95% air and 80% humidity at 37'C.
Iodination of hGH. Human GH was iodinated by the iodogen technique described by Salacinski et al. (1981) to give ["'II-hGH with a specific activity of 80-100 pCilpg. [I2'I]-hGH was then purified by chromatography on an FPLC Superose column immediately before use in each binding assay.
Radioreceptor Assays. Radioreceptor assays on IM9 cells were carried out by the method of Lesniak et al. (1973) . Cells were suspended at a concentration of 2.5 x 10'lmI in 100 mM Hepes. pH 7, containing 120 mM sodium chloride, 1.2 mM magnesium sulfate, 15 mM sodium acetate, 2.5 mM potassium chloride, 10 mM glucose, 1 mM EDTA, and 1 mglml bovine serum albumin (assay buffer). The cells were incubated with a fixed amount of radiolabeled hGH and increasing concentrations of unlabeled hGH or biotinylated hGH for 90 min at 30'C. Nonspecific binding was determined in the presence of 4 pglml unlabeled hormone. The reaction was terminated by layering aliquors onto cold assay buffer and separating bound and free hormone by centrifugation at 7500 x gav for 1 min. The supernatant fractions were aspirated and radioactivity in the pellets was counted in a gamma counter.
Bioassay. The bioactivity of biotinylated hGH was compared with that of unlabeled hGH using the Nb2 bioassay as described by Tanaka et al. (1980) . in which cells grow at a rate proportional to the concentration of lactogenic hormones present. Nb2 cells were synchronized 18 hr before the assay as described by Gout et al. (1980) . Cells were re-suspended in RPMI-1640 with 10% (vlv) horse serum at 2 x 10'lml and incubated with increasing concentrations of hGH or biotinylated hGH for 3 days. Cell numbers were then determined with a Coulter counter (Coulter Electronics; Luton. UK).
Histochemistry. IM9 cells were centrifuged onto slides using a Cyrospin. The cells were air-dried for 30 min and fixed in 1:1 acetone:methanol for 1 min. Fixed cells were incubated with 1% (vlv) H202 in methanol for 20 min at room temperature (RT) to block endogenous peroxidase activity. The cells were incubated in assay buffer for 10 min and then with biotinylated hGH (1-10 pM). with or without unlabeled hGH at a 5O-fold molar excess for 90 min at RT. Control incubations without biotinylated hormone were also included. Cells were then washed with PBS and incubated with Vectasrain ABC complex (Vector Laboratories; Burlingame. CA) for 30 min before being washed with PBS and incubated with 0.05% (wlv) diaminobenzidine and 0.1% (vlv) H202 in PBS for 10 min. Finally, the cells were washed with PBS and counterstained with Carazzi's hematoxylin before dehydrating and mounting in DPX (BDH Chemicals; Poole. UK).
Results
Biotinylation of hGH was confirmed by electrophoresis, followed by transfer to nitrocellulose. The nitrocellulose was incubated with fluorescein-avidin and viewed under uv light. A single band with a molecular weight of 22 KD was obtained (Figure 1 ). Mass spectrometry revealed the production of two major biotinylated forms of hGH (Figure 2) . Unlabeled hGH comprised 35-40%, monobiotinylated hGH comprised about 50%. and dibiotinylated hGH comprised 10-15% of the preparation.
To investigate receptor binding activity, IM9 cells were incubated with a fixed amount of radiolabeled hGH and increasing concentrations of either biotinylated hGH preparation or unlabeled hGH (Figure 3 ). Scatchard (1949) analysis revealed that the affinity of unlabeled hGH was 1.04 x lo9 M-' (SD = 0.74; n = 13). whereas the affinity of the mixed biotinylated hGH preparation was 0.55
x lo9 M-' (SD = 0.36; n = 5). Since mass spectrometry showed that unlabeled hGH constituted up to 40% of the mixture, it is likely that we have overestimated the affinity of monobiotinylated hGH.
Comparison of the bioactivity of biotinylated hGH and unmodified hGH in the Nb3 assay produced growth curves that were iden--22 kDa tical in shape, but the preparation of biotinylated G H was approximately 53.9% (SD = 24.3%; n = 3) as active as unlabeled GH (Figure 4) . As with measurement of affinity for receptor, this is likely to be an overestimation for the bioactivity of monobiotinylated GH, since the preparation used contained a significant amount of GH that had not been biotinylated.
Histochemical localization of hGH bound to IM9 cells with biotinylated hGH is illustrated in Figure 5A . The intensity of staining varied between cells and was most intense at the cell membrane. Controls incubated without biotinylated hGH showed no staining (not shown). The stain was shown to be specific for GH binding, since it could be competed with a 50-fold molar excess of unlabeled hGH ( Figure SB) .
Discussion
In the present study we biotinylated hGH and demonstrated that although modification of the hormone causes some decrease in bioactivity and ability to bind to receptor, biotinylated hGH can be used effectively for histological identification of binding to cells expressing specific receptors.
Attachment of biotin to GH was confirmed by electrophoresis, but biotinylation via hydroxysuccinimide esters occurs at the amino groups of lysine residues, including two of the lysine residues in GH (amino acids 41 and 168) which interact with the receptor binding site (de Vos et al., 1992) . We found a 50% reduction in both affinity of biotinylated hGH for the GH receptor of IM9 cells and bioactivity in the Nb2 bioassay, although the presence of GH that had not been biotinylated (up to 40%) makes it likely that we have overestimated bioactivity and receptor binding activity of the biotinylated derivative. Mass spectrometry showed that about 50% of GH molecules were monobiotinylated, so it is likely that purification of this species would lead to an improvement in the histochemical technique.
Recombinant hGH was first directly biotinylated without a spacer arm by Haeuptle et al. (1983) , who used the modified hormone to extract solubilized receptors from tissues but did not describe its use for histology. Michel and Parsons (1988) biotinylated ovine prolactin without use of a spacer arm but later revealed that the modified hormone had not proved useful for histochemical detection of prolactin receptors (Michel and Parsons, 1990) . In initial studies we found that directly biotinylated hGH (without spacer) did not give positive results in histochemical procedures, whereas subsequent use of a six-carbon spacer arm produced clear and specific staining (Figure 4) . These results suggest that after binding of GH and prolactin to receptors, steric hindrance prevents binding of avidin to the biotinylated hormone unless a spacer arm is used.
Even using a spacer arm we were initially unable to obtain reproducible staining with avidin-labeled peroxidase. This problem was overcome by use of the Vectastain ABC reagent, which consists of a pre-formed complex of avidin and biotinylated peroxidase, giving considerable amplification. Effective blocking of endogenous peroxidase activity in all experiments was demonstrated by lack of staining in the absence of biotinylated hormone.
The I M~ human lymphoid cell line has been well characterized and is known to have 3000-4000 receptors for GH per cell (Lesniak et al., 1973) . As these cells do not express prolactin receptors they were an obvious choice for developing this histochemical technique. Interestingly, not all cells were stained. Possible explanations for this result include heterogeneity in the IM9 cell line used and variation in receptor expression during the cell cycle. The binding results obtained give an indication of the sensitivity of the technique in its ability to detect receptors at such a low concentration.
These results demonstrate that biotinylated hGH can be used as aprobe for identification of GH-binding sites on cultured cells, and the technique can also be applied to frozen sections (Bentham et al., 1991) . The direct visualization of GH-binding sites on human cells will facilitate investigation of binding, particularly in heterogeneous cell populations.
